| Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study K Ben Hassine, T Nava, Y Théoret, CE Nath, Y Daali, N Kassir, V Lewis, ... CPT: pharmacometrics & systems pharmacology 10 (9), 1043-1056, 2021 | 18 | 2021 |
| The analysis of GSTA1 promoter genetic and functional diversity of human populations V Mlakar, PHD Curtis, M Armengol, V Ythier, I Dupanloup, KB Hassine, ... Scientific reports 11 (1), 5038, 2021 | 12 | 2021 |
| Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia K Ben Hassine, M Powys, P Svec, M Pozdechova, B Versluys, M Ansari, ... Frontiers in Pediatrics 9, 775485, 2021 | 8 | 2021 |
| A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico … S Robin, KB Hassine, J Muthukumaran, S Jurkovic Mlakar, M Krajinovic, ... BMC molecular and cell biology 23 (1), 1-29, 2022 | 2 | 2022 |
| Precision medicine in the treatment of pediatric cancers B Hassine, F Ceppi, F Baleydier, AO Von Bueren, M Ansari Revue Medicale Suisse 19 (815), 380-387, 2023 | 1 | 2023 |
| The Catalytic Activity of GSTM1 In vitro is Independent of MAPK8 S Robin, K Ben Hassine, SJ Mlakar, V Mlakar, M Ansari, ... Drug Metabolism Letters 14 (3), 163-165, 2021 | 1 | 2021 |
| Pharmacokinetic modeling and simulation with pharmacogenetic insights support the relevance of therapeutic drug monitoring for myeloablative busulfan dosing in adult HSCT. KB Hassine, C Seydoux, S Khier, Y Daali, M Medinger, J Halter, D Heim, ... Transplantation and Cellular Therapy, 2023 | | 2023 |
